Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.890
+0.050 (2.72%)
At close: Oct 7, 2025, 4:00 PM EDT
1.920
+0.030 (1.57%)
After-hours: Oct 7, 2025, 5:05 PM EDT
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $86.30 million as of October 7, 2025. Its market cap has increased by 17.04% in one year.
Market Cap
86.30M
Enterprise Value
75.65M
1-Year Change
17.04%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.77M to $86.30M, an increase of 20.25%. That is a compound annual growth rate of 2.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 86.30M | 10.53% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | 19.83M | -23.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |